MORGAN STANLEY - BIONDVAX PHARMACEUTICALS LTD ownership

BIONDVAX PHARMACEUTICALS LTD's ticker is and the CUSIP is 09073Q204. A total of 12 filers reported holding BIONDVAX PHARMACEUTICALS LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of BIONDVAX PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$1,985
-35.5%
2,282
+4.6%
0.00%
Q2 2023$3,077
-36.9%
2,182
-3.3%
0.00%
Q1 2023$4,875
-41.6%
2,257
-19.9%
0.00%
Q4 2022$8,3412,8180.00%
Other shareholders
BIONDVAX PHARMACEUTICALS LTD shareholders Q1 2023
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 325,974$704,1040.61%
Virtu Financial LLC 10,508$230.00%
NewSquare Capital LLC 2$40.00%
UBS Group AG 5,322$11,4960.00%
CREDIT AGRICOLE S A 424$9160.00%
WELLS FARGO & COMPANY/MN 20$430.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MILLENNIUM MANAGEMENT LLC 43,604$940.00%
MORGAN STANLEY 2,257$4,8750.00%
Global Retirement Partners, LLC 50$950.00%
View complete list of BIONDVAX PHARMACEUTICALS LTD shareholders